Sanofi (SNY) Short-term Investments (2009 - 2021)

Sanofi (SNY) has 13 years of Short-term Investments data on file, last reported at $12.5 million in Q4 2021.

• Quarterly Short-term Investments fell 93.18% year-over-year to $12.5 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $12.5 million (down 93.18% YoY) and the FY2021 annual result came in at $12.9 million, down 92.64% from the prior year.
• Short-term Investments slipped to $12.5 million in Q4 2021 per SNY's latest filing, from $182.9 million in the prior quarter.
• The five-year high for Short-term Investments was $227.1 million in Q4 2018, with the low at $12.5 million in Q4 2021.
• Average Short-term Investments over 5 years is $132.0 million, with a median of $147.0 million recorded in 2019.
• Year-over-year, Short-term Investments soared 170.86% in 2017 and plunged 93.18% in 2021.
• Sanofi's Short-term Investments stood at $90.7 million in 2017, then jumped by 150.53% to $227.1 million in 2018, then sank by 35.28% to $147.0 million in 2019, then rose by 24.42% to $182.9 million in 2020, then tumbled by 93.18% to $12.5 million in 2021.
• Business Quant data shows SNY's Short-term Investments at $12.5 million in Q4 2021, $182.9 million in Q4 2020, and $147.0 million in Q4 2019.